
Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …

A new report has canvassed the intentions of industry players in the use of real world data and evidence over …

Pharmafocus talks to John Ellwood about the challenges of being diagnosed with multiple myeloma and how having a strong support …

As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how …

Pamela Yeh, Assistant Professor at the Department of Ecology and Evolutionary Biology, University of California, Los Angeles, discusses how drug …

The US presidential election is mere weeks away, and the pharmaceutical industry and drug pricing have occupied quite a large …